CTOs on the Move


 
XORTX Therapeutics Inc. is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease. XORTX has lead programs to develop treatments for progressive kidney disease due to diabetes, diabetic nephropathy, and polycystic kidney disease. Secondary programs focus on developing therapies for health consequences that accompany pre-diabetes, diabetes and cardiovascular disease.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.xortx.com
  • 4000, 421 - 7th Avenue SouthWest
    Calgary, AB CAN T2P 4K9
  • Phone: 403.455.7727

Executives

Name Title Contact Details
David MacDonald
Chief Technology Officer Profile

Similar Companies

Pfeiffer Pharmaceuticals

Pfeiffer Pharmaceuticals is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Fifty 50 Pharmacy

Fifty 50 Pharmacy is a Carrollton, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Genactis

Genactis is a Fort Washington, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nycomed US Inc

Nycomed US Inc is a Florham Park, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medican Enterprises Inc.

Medican Enterprises is a bio-pharmaceutical company focused on developing, distributing and marketing pharmaceutical grade cannabis to the emerging global medical marijuana market. It’s wholly owned subsidiary Medican Systems Inc. is an industry leader in the design, construction and operation of Medical Marijuana and Cultivation Centers across Canada and the United States. Traded on the OTCBB, Medican drives shareholder value through its scalable business model and commitment to scientific research, operational excellence and regulatory compliance.